Loading...
North Bud Farms Inc.
NOBDF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$0.00(0.00%)

Over the last four quarters, North Bud Farms Inc.'s revenue moved from $0.00 in Q4 2018 to $0.00 in Q3 2019. Operating income in Q3 2019 was -$459322.00, with a strong operating margin of N/A. Despite fluctuations in R&D and SG&A expenses, EBITDA for North Bud Farms Inc. remained robust at -$459322.00, reflecting operational efficiency. Net income dropped to -$452356.00, with an EPS of -$0.007. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan